Abstract
In the current study, performance of electrochemiluminescence immunoassay (ECLIA) in detection of anti-toxoplasma IgG in human sera was compared with that of enzyme-linked immunosorbent assay (ELISA). Furthermore, performance of an in house Dot-ELISA in detection of anti-toxoplasma IgG was compared with that of ECLIA and ELISA. In total, 219 human sera were tested to detect anti-toxoplasma IgG using Dynex DS2® and Roche Cobas® e411 Automated Analyzers. Discordant results rechecked using immunofluorescence assay (IFA). Then, sera were used in an in house Dot-ELISA to assess toxoplasma-specific IgG. Of the 219 samples, two samples were found undetermined using ECLIA but reactive using ELISA. Using IFA, the two sera were reported unreactive. Furthermore, two samples were found reactive using ECLIA and unreactive using ELISA. These samples were reported reactive using IFA. The overall agreement for the two former methods was 98% (rZ0.98.1; P < 0.001). The intrinsic parameters calculated for in house Dot-ELISA included sensitivity of 79.5, specificity of 78.2, and accuracy of 78.9%, compared to ECLIA and ELISA. Positive and negative predictive values included 82.9 and 74.2%, respectively. A 100% sensitivity was found in in house Dot-ELISA for highly reactive sera in ECLIA and ELISA. ECLIA is appropriate for the first-line serological screening tests and can replace ELISA due to high speed, sensitivity, and specificity, particularly in large laboratories. Dot-ELISA is a rapid, sensitive, specific, cost-effective, user-friendly, and field-portable technique and hence can be used for screening toxoplasmosis, especially in rural fields or less equipped laboratories.
Similar content being viewed by others
Abbreviations
- ECLIA:
-
electrochemiluminescence immunoassay
- ELISA:
-
enzyme-linked immunosorbent assay
- IgG:
-
immunoglobulin G
- DT:
-
dye test
- IFA:
-
immunofluorescence assay
- CFT:
-
complement fixation test
- MAT:
-
modified agglutination test
- LAT:
-
latex agglutination test
- DAT:
-
direct agglutination test
- IFAT:
-
indirect fluorescent antibody test
- IHA:
-
indirect hemagglutination assay
- PBS-M 3%:
-
phosphate-buffered saline containing 3% of non-fat dry milk
- PBS-T:
-
phosphate-buffered saline containing tween 20
- HRP:
-
horseradish peroxidase
- OPD:
-
ortho phenylenediamine
- OD:
-
optical density
- NC:
-
nitrocellulose membrane
- IBM:
-
International Business Machines Corporation
- SPSS:
-
Statistical Package for the Social Sciences
References
Dubey JP (2010). Toxoplasmosis of animals and humans. 2rd edn. CRC Press Inc. Boca Raton, New York, pp 1–313
Alvarado-Esquirel C, Estrada-Martinez S, Liesenfeld O (2011) Toxoplasma gondii infection in workers occupationally exposed to unwashed raw fruits and vegetables: a case control seroprevalence study. Parasit Vectors 16:4–235
Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30:1217–1258
Walle F, Kebede N, Tsegaye A, Kassa T (2013) Seroprevalence and risk factors for toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia. Parasit Vectors 6:15–10
Tuazon CU (1989) Toxoplasmosis in AIDS patients. J Antimicrob Chemother 23(suppl A):77–82
Robert-Gangneux F, Darde ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25:264–296
Liu Q, Wang Z-D, Huang S-Y, Zhu X-Q (2015) Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors 8(1):292
Acharya D, Bastola P, Le L, Paul AM, Fernandez E, Diamond MS et al (2016) An ultrasensitive electrogenerated chemiluminescence-based immunoassay for specific detection of Zika virus. Sci Rep 2016(6):32227
Dard C, Fricker-Hidalgo H, Brenier-Pinchart MP, Pelloux H (2016) Relevance of and new developments in serology for toxoplasmosis. Trends Parasitol 32:492–506
Pappas MG, Hajkowski R, Hockmeyer WT (1983) Dot enzyme-linked immunosorbent assay (Dot-ELISA): a micro technique for the rapid diagnosis of visceral leishmaniasis. J lmmlmologcal Methods 64:205–214
Gupta A, Dixit AK, Dixit P (2008) Dot-ELISA in the diagnosis of parasitic diseases of animals. J Parasit Dis 32(1):10–14
Zhang K, Lin G, Han Y, Li J (2016) Serological diagnosis of toxoplasmosis and standardization. Clin Chim Acta 46:83–89
Marquette CA, Blum LJ (2008) Electro-chemiluminescent biosensing. Anal Bioanal Chem 390:155–168
Ali-Heydari S, Keshavarz H, Shojaee S, Mohebali M (2013) Diagnosis of antigenic markers of acute toxoplasmosis by IgG avidity immunoblotting. Parasite 20(18):20–18
Hawkes R, Niday E, Gordon J (1982) A dot-immunobinding assay for monoclonal and other antibodies. Anal Biochem 119(1):142–147
Pappas MG (1988) Recent applications of the Dot-ELISA in immunoparasitology. Vet Parasitol 29(2–3):105–129
IBM Corp Released (2012) IBM SPSS statistics for windows, version 21.0. Armonk, NY: IBM Corp
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174
Jacobson RH (1998) Validation of serological assays for diagnosis of infectious diseases. Rev Sci Tech 17(2):469–526
Hayde M, Salzer HR, Gittler G, Aspock H, Pollak A (1995) Microparticle enzyme immunoassay (MEIA) for toxoplasma specific immunoglobulin G in comparison to the Sabin-Feldman dye test. A pilot study. Wien Klin Wochenschr 107:133–136
Kasper DC, Prusa AR, Hayde M, Gerstl N, Pollak A, Herkner KR, Reiter-Reisacher R (2009) Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women. J Clin Microbiol 47:164–167
Petersen E, Borobio MV, El G et al (2005) European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol 43:1570–1574
Tekkesin N, Keskin K, Kılınc C, Orgen N, Molo K (2011) Detection of immunoglobulin G antibodies to Toxoplasma gondii: evaluation of two commercial immunoassay systems. J Microbiol Immunol Infect 44:21–26
Prusa AR, Hayde M, Unterasinger L, Pollak A, Herkner KR et al (2010) Evaluation of the Roche Elecsys Toxo IgG and IgM electrochemiluminescence immunoassay for the detection of gestational Toxoplasma infection. Diagn Microbiol Infect Dis 68(4):352–357
Murat JB, Hidalgo HF, Brenier-Pinchart MP, Pelloux H (2013) Human toxoplasmosis: which biological diagnostic tests are best suited to which clinical situations? Expert Rev Anti-Infect Ther 11(9):943–956
Wilson M, Remington JS, Clavet C, Varney G, Press C, Ware D (1997) Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. J Clin Microbiol 35:3112–3115
Syme NR, Toft AD, Stoddart M, Beckett GJ (2011) Clinical performance of the Roche cobas e411 automated assay system for thyrotropin-receptor antibodies for the diagnosis of Graves’ disease. Ann Clin Biochem 48(5):471–473
Selseleh M, Keshavarz H, Mohebali M, Shojaee S, et al (2012) Production and Evaluation of Toxoplasma gondii Recombinant GRA7 for Serodiagnosis of Human Infections. Korean J Parasitol 50(3):233–238
Leser PG, de Assis Rocha LS, Moura MEG, Ferreira AW (2003) Comparison of semi-automatized assays for anti-T. gondii IgG detection in low-reactivity serum samples: importance of the results in patient counseling. J Bras Patol Med Lab 39:107–110
Meylan P, Paris L, Liesenfeld O (2015) Multicenter evaluation of the Elecsys Toxo IgG and IgM tests for the diagnosis of infection with Toxoplasma gondii. Eur J Microbiol Immunol 5(2):150–158
Prusa AR, Hayde M, Unterasinger L, Pollak A, Herkner KR et al (2010) Evaluation of the Roche Elecsys Toxo IgG and IgM electrochemiluminescence immunoassay for the detection of gestational Toxoplasma infection. Diagn Microbiol Infect Dis 68:352–357
Van Helden J (2009) Performance of Elecsys toxo IgG and IgM immunoassays. Clin Lab 55:267–273
Murat JB, L’Ollivier C, Fricker Hidalgo H, Franck J, Pelloux H et al (2012) Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results. Clin Vaccine Immunol 19:1838–1843
Schaefer LE, Dyke JW, Meglio FD, Murray PR, Crafts W, Niles AC (1989) Evaluation of microparticle enzyme immunoassays for immunoglobulins G and M to rubella virus and Toxoplasma gondii on the Abbott IMx automated analyzer. J Clin Microbiol 27:2410–2413
Selseleh M, Keshavarz H, Mohebali M, Shojaee S, Modarressi MH, Eshragian M (2012) Production and evaluation of Toxoplasma gondii recombinant surface antigen 1 (SAG1) for serodiagnosis of acute and chronic Toxoplasma infection in human sera. Iran J Parasitol 7:1–9
Tenter AM (1988) Comparison of Dot-ELISA, ELISA and IFAT for the detection of IgG antibodies to Sarcocystis muris in experimentally infected and immunized mice. Vet Parasit 29:89–104
Vercammen F, Berkvens D, Brandt J, Vansteenkiste W (1998) A sensitive and specific 30-min Dot-ELISA for the detection of anti-leishmania antibodies in the dog. Vet Parasitol 79:221–228
Wanduragala L, Kakoma I, Clabaugh GW, Abeygunawardena I, Levy MG, Ristic M (1987) Development of dot-enzyme immunoassay for diagnosis of canine babesiosis. Am J Trop Med Hyg 36:20–21
Montenegro James S, Guillen AT, Toro M (1992) Dot-ELISA para el diagnostico serologico de la anaplasmosis y babesiosis bovina. Rev Ciesstifica FCV de Luz II:23–29
Camus E, Montenegro James S (1994) Bovine anaplasmosis and babesiosis in the lesser antilles: risk assessment of an unstable epidemiologic situation. Vet Res 25:313–317
Mattioli RC, Janneh L, Corr N, Faye JA, Pandey US, Verhulet A (1997) Seasonal prevalence of ticks and tick transmitted haemoparasites in traditionally managed N’Dama cattle with reference to strategic tick control in the Gambia. Med Vet Entomol 11:342–348
Jafarpour Azami S, Keshavarz H, Rezaian M, Mohebali M, Shojaee S (2011) Rapid detection of Toxoplasma gondii antigen in experimentally infected mice by dot-ELISA. Iranian J Parasitol 6:28–33
Siavashi MR, Taherkhani H, Rezaei KR, Razavi Deligani MR, Assmar M (2005) Comparison of dot-ELISA and sandwich ELISA diagnostic tests in detection of human hydatidosis. Iran Biomed J 9:91–94
Acknowledgements
We would like to acknowledge all staff from the toxoplasmosis laboratory (Department of Medical Parasitology and Mycology, Tehran University of Medical Sciences, Tehran, Iran) for their useful collaboration.
Funding
This study was supported by the Tehran University of Medical Sciences and Health Services (Project Number: 29999-160-03-94), Tehran, Iran.
Author information
Authors and Affiliations
Contributions
HK and MHM conceived the study. NZ collected and prepared the samples. AT performed the experiments with substantial contributions by SS. AT drafted the manuscript and revised by SS, MM, and MR. All authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was approved by the Ethical Committee of Tehran University of Medical Sciences.
Consent for publication
Not applicable (no individual person’s data).
Availability of data and material
The data that support the findings of this study are available on reasonable request to the corresponding author.
Competing interests
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Teimouri, A., Modarressi, M.H., Shojaee, S. et al. Detection of toxoplasma-specific immunoglobulin G in human sera: performance comparison of in house Dot-ELISA with ECLIA and ELISA. Eur J Clin Microbiol Infect Dis 37, 1421–1429 (2018). https://doi.org/10.1007/s10096-018-3266-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-018-3266-y